Evidence map›Paper›PMID 42262151›Full record

ArticleAnnals of the New York Academy of Sciences2026

Enhancing Preclinical Rigor: Evaluating Robustness and Numerical Stability in a Chronic Pancreatitis Mouse Model.

Annika Thämlitz, Muhammad Imran Khan, Benjamin Schulz, Lorenzo Pilch, Brigitte Vollmar, Dietmar Zechner

Abstract read
In one paragraph

Article in Annals of the New York Academy of Sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Annika ThämlitzInstitute for Experimental Surgery, University Medical Centre Rostock, Rostock, Germany.ORCID https://orcid.org/0009-0005-7621-6793
Muhammad Imran KhanInstitute for Experimental Surgery, University Medical Centre Rostock, Rostock, Germany.ORCID https://orcid.org/0000-0003-0276-5480
Benjamin SchulzInstitute for Experimental Surgery, University Medical Centre Rostock, Rostock, Germany.ORCID https://orcid.org/0009-0005-1598-0392
Lorenzo PilchInstitute for Experimental Surgery, University Medical Centre Rostock, Rostock, Germany.ORCID https://orcid.org/0009-0008-5017-6801
Brigitte VollmarInstitute for Experimental Surgery, University Medical Centre Rostock, Rostock, Germany.ORCID https://orcid.org/0000-0002-2403-9597
Dietmar ZechnerInstitute for Experimental Surgery, University Medical Centre Rostock, Rostock, Germany.ORCID https://orcid.org/0000-0002-2075-7540

Funding

Deutsche Forschungsgemeinschaft VO450/15-2Deutsche Forschungsgemeinschaft VO450/15-3Deutsche Forschungsgemeinschaft ZE712/1-2Deutsche Forschungsgemeinschaft ZE712/1-3(FOR2591)
6 · The paper itself

Abstract

Chronic pancreatitis (CP) is characterized by progressive fibrosis, inflammation, and pancreatic atrophy. Here, we evaluate a milder CP model using only 42 cerulein injections administered in both male and female C57BL/6J (BL6) and BALB/c mice. We further assess the therapeutic potential of the RORγt inhibitor GSK805. We employed a multi-tiered analytical approach, including the robustness of conclusion (RC), unit fragility index, and robustness index, to evaluate consistency and numerical stability of conclusions. The model reliably produced key hallmarks of CP: reduced pancreas-to-body weight ratio, elevated collagen I deposition, and tubular complex formation with an RC of 100%. In contrast, the induction of Tnf, Ifng, Il10, Il23r, Il6, and Il1b expression was less robust and partially strain specific. Il23r and Il10 were significantly induced during CP in female and male BL6 but not in BALB/c mice. Il6 was significantly induced in female and male BALB/c but only reached significance in BL6 when sexes were combined. Treatment with GSK805 reduced Il23r expression level significantly in BL6 mice, but no reliable improvements in other disease characteristics were observed. Overall, this study validates a simplified, robust CP model and advocates for the integration of complementary statistical metrics to strengthen the reliability of scientific conclusion.

Indexed as

Disease Models, AnimalPancreatitis, ChronicAnimalsCeruletideFemaleGastrointestinal AgentsMaleMiceMice, Inbred BALB CMice, Inbred C57BLNuclear Receptor Subfamily 1, Group F, Member 3PancreasCeruletideGastrointestinal AgentsNuclear Receptor Subfamily 1, Group F, Member 3cerulein‐induced chronic pancreatitisGSK805 therapyreliability of researchrobustness indexrobustness of conclusionunit fragility index

Identifiers

PMID42262151
PMCPMC13248879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.